楼主: bigfoot0518
1124 0

[外行报告] 2010年1月巴西医疗行业研究报告 [推广有奖]

学术权威

70%

还不是VIP/贵宾

-

威望
10
论坛币
10441579 个
通用积分
6.7997
学术水平
1222 点
热心指数
923 点
信用等级
1220 点
经验
65985 点
帖子
2052
精华
21
在线时间
405 小时
注册时间
2008-12-11
最后登录
2021-8-16

相似文件 换一批

+2 论坛币
k人 参与回答

经管之家送您一份

应届毕业生专属福利!

求职就业群
赵安豆老师微信:zhaoandou666

经管之家联合CDA

送您一个全额奖学金名额~ !

感谢您参与论坛问题回答

经管之家送您两个论坛币!

+2 论坛币
【出版时间及名称】:2010年1月巴西医疗行业研究报告
        【作者】:德意志银行
        【文件格式】:pdf
        【页数】:49
        【目录或简介】:

Table of Contents
Sector Investment Thesis ................................................................. 3
Our check-up points to healthy sector fundamentals................................................................3
The Brazilian healthcare landscape ................................................. 6
Revisiting the main sector trends and issues............................................................................6
OdontoPrev ...................................................................................... 12
Investment summary ..............................................................................................................12
Earnings outlook .....................................................................................................................14
Valuation ................................................................................................................................16
Risks ......................................................................................................................................16
Amil/Medial ..................................................................................... 19
Investment Summary..............................................................................................................19
Earnings outlook .....................................................................................................................20
Valuation ................................................................................................................................22
Risks ......................................................................................................................................23
DASA ................................................................................................ 25
Investment Summary..............................................................................................................25
Earnings Outlook.....................................................................................................................25
Valuation ................................................................................................................................27
Risks ......................................................................................................................................27
Fleury ................................................................................................ 29
Investment Summary..............................................................................................................29
Earnings outlook .....................................................................................................................29
Valuation ................................................................................................................................31
Risks ......................................................................................................................................31
Fleury under the microscope.......................................................... 33
Company Description .............................................................................................................33
Fleury’s Business Units...........................................................................................................33
Fleury’s Strategy/Restructuring...............................................................................................35
Acquisitions have been major driver in recent expansion .......................................................37
Fleury vs. DASA......................................................................................................................38
Shareholders’ Structure ..........................................................................................................41
Management..........................................................................................................................42
Appendix: Valuation Comps........................................................... 43
二维码

扫码加我 拉你入群

请注明:姓名-公司-职位

以便审核进群资格,未注明则拒绝

关键词:行业研究报告 医疗行业 研究报告 行业研究 Acquisitions 研究报告 行业 医疗 巴西

db 巴西医疗 1.pdf

686.32 KB

需要: 10000 个论坛币  [购买]

您需要登录后才可以回帖 登录 | 我要注册

本版微信群
加JingGuanBbs
拉您进交流群

京ICP备16021002-2号 京B2-20170662号 京公网安备 11010802022788号 论坛法律顾问:王进律师 知识产权保护声明   免责及隐私声明

GMT+8, 2024-5-18 03:24